vTv Therapeutics Reinitiates Screening in CATT1 Phase 3 Trial
15 May 2025 //
GLOBENEWSWIRE
vTv Therapeutics: FDA Lifts Clinical Hold on Cadisegliatin Program
17 Mar 2025 //
GLOBENEWSWIRE
vTv Announces FDA Submission for First Phase 3 Study of Cadisegliatin
04 Mar 2024 //
GLOBENEWSWIRE